Safety of Simultaneous Hepatectomy and Splenectomy in the Treatment of Hepatocellular Carcinoma Complicated with Hypersplenism: A Meta-analysis
Open Access
- 14 August 2019
- journal article
- review article
- Published by Wiley in Gastroenterology Research and Practice
- Vol. 2019, 1-17
Abstract
Background. We conducted this meta-analysis to compare the efficacy and safety of simultaneous hepatectomy and splenectomy (HS) with hepatectomy alone (HA) in patients with hepatocellular carcinoma (HCC) and hypersplenism. Materials and Methods. A systematic search was conducted in PubMed, Embase, Cochrane Library, and Wanfang Data through March 1, 2018, with no limits. Two investigators independently screened all retrieved studies. The investigators of the original publications were contacted if required information was absent. All the included studies were managed by EndNote X7. Quality assessment of the included studies was performed using a modified Newcastle-Ottawa Scale judgment. Extracted data for each endpoint were analyzed by using STATA 12.0 software. Results. Thirteen studies, including a total of 1468 patients, comparing the effects of HS with HA were pooled in this meta-analysis. Outcomes including postoperative complications, perioperative mortality, intraoperative blood transfusion, and albumin (ALB) content at postoperation day (POD) 7 did not differ significantly between the two groups. Simultaneous approaches significantly promoted 1-, 3-, and 5-year disease-free survival (DFS) rates and overall survival (OS) rates, prolonged operation time, aggravated intraoperative blood loss, increased white blood cell (WBC) and platelet (PLT) counts at POD 7, and lowered total bilirubin (T-Bil) contents at POD 1 and 7. Conclusion. Compared to HA, HS is safer and more effective in ameliorating liver function and improving survival of HCC patients complicated with hypersplenism. This trial is registered with CRD42018093779.Keywords
Funding Information
- National Natural Science Foundation of China (81874178, 81572328, ZR2014HQ043, tsqn20161064)
- National Natural Science Foundation of China (81874178, 81572328, ZR2014HQ043, tsqn20161064)
- Natural Science Foundation of Shandong Province (81874178, 81572328, ZR2014HQ043, tsqn20161064)
- Shandong Province (81874178, 81572328, ZR2014HQ043, tsqn20161064)
This publication has 47 references indexed in Scilit:
- Prevention and Management of Complications of Laparoscopic SplenectomyIndian Journal of Surgery, 2011
- Comparison of liver regeneration after a splenectomy and splenic artery ligation in a dimethylnitrosamine-induced cirrhotic rat modelHPB, 2010
- Recent role of splenectomy in chronic hepatic disordersHepatology Research, 2008
- The postoperative splenic/portal vein thrombosis after splenectomy and its prevention - an unresolved issueHaematologica, 2008
- Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in ratsSurgery, 2007
- Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenismBritish Journal of Surgery, 2005
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Platelets accumulation in the liver after partial hepatectomy: The role of platelets in liver regenerationJournal of Hepatology, 2000
- Splenectomy in patients with hepatocellular carcinoma and hypersplenism1Journal of the American College of Surgeons, 2000
- Role of Kupffer cells and the spleen in modulation of endotoxin-induced liver injury after partial hepatectomyHepatology, 1996